BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/8/2015 3:25:00 PM | Browse: 1373 | Download: 3040
 |
Received |
|
2014-11-24 08:43 |
|
Peer-Review Started |
|
2014-11-24 10:28 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-12-24 10:29 |
|
Revised |
|
2015-02-10 19:38 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2015-04-07 17:16 |
|
Second Decision by Editor-in-Chief |
|
2015-04-08 03:46 |
|
Final Decision by Editorial Office Director |
|
2015-04-09 16:57 |
|
Articles in Press |
|
2015-04-09 17:17 |
|
Edit the Manuscript by Language Editor |
|
2015-06-01 18:16 |
|
Typeset the Manuscript |
|
2015-07-23 19:40 |
|
Publish the Manuscript Online |
|
2015-08-08 15:26 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Arghavan Haj-sheykholeslami, Maryam Keshvari, Heidar Sharafi, Ali Pouryasin, Khalil Hemmati and Fatemeh Mohammadzadehparjikolaei |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Pooyesh Darou which is the local manufacturer of pegylated interferon alpha-2a in Iran (Pegaferon) |
|
|
| Corresponding Author |
Maryam Keshvari, MD, Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran 14665-1157, Iran. m.keshvari@ibto.ir |
| Key Words |
Chronic hepatitis C; Pegylated interferon; rs12979860; rs8099917; Sustained virologic response |
| Core Tip |
Chronic hepatitis C-infected Iranian patients treated with pegylated interferon and ribavirin showed relatively high rates of sustained virologic response. Treatment success was not influenced by hepatitis C virus genotype. However, comparison of treatment success with IFNL polymorphisms (also known as IL28B polymorphisms) using a logistic regression analysis revealed that the interferon-λ rs12979860 CC genotype was significantly associated with achieving sustained virologic response. |
| Publish Date |
2015-08-08 15:26 |
| Citation |
Haj-sheykholeslami A, Keshvari M, Sharafi H, Pouryasin A, Hemmati K, Mohammadzadehparjikolaei F. Interferon- polymorphisms and response to pegylated interferon in Iranian hepatitis C patients. World J Gastroenterol 2015; 21(29): 8935-8942 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i29/8935.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i29.8935 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
